Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05175196 · ClinicalTrials.gov registry record · NA
CandyCollect Strep Throat Testing
A NA study of Group A Streptococcal Infection, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 210
- Enrollment target
- 1
- Study location
NCT05175196: Recruiting NA study of Group A Streptococcal Infection, sponsored by University of Wisconsin, Madison.
NCT05175196 is a NA study of Group A Streptococcal Infection that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 210 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05175196, a NA study of Group A Streptococcal Infection, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll children ages 5-17 who test positive for Group A Streptococcus (GAS) at a single clinic visit lasting approximately 30-60 minutes. The primary aim of this study is to assess the accuracy and feasibility of the CandyCollect platform to capture and detect GAS. The investigators hypothesize that the CandyCollect platform is non-inferior to gold-standard rapid antigen detection testing for GAS.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST CandyCollect
- DIAGNOSTIC_TEST Lollipop Swab
Study Locations (1)
Wisconsin
- University of Wisconsin Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT05175196 shows while recruiting
NCT05175196 is an interventional study that assigns participants to a tested intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Group A Streptococcal Infection appearing as the primary indexed condition, and to 2 interventions - of which CandyCollect is the first listed.
NCT05175196 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05175196 about?
NCT05175196 is a clinical study titled "CandyCollect Strep Throat Testing". This study will enroll children ages 5-17 who test positive for Group A Streptococcus (GAS) at a single clinic visit lasting approximately 30-60 minutes. The primary aim of this study is to assess the accuracy and feasibility of the CandyCollect platform to capture and detect GAS. The investigators ...
What is the current status of trial NCT05175196?
This trial is currently recruiting. It is a NA study. The enrollment target is 210 participants. The study started on 2023-01-10. Estimated completion is 2026-03.
What conditions does trial NCT05175196 study?
This clinical trial studies the following conditions: Group A Streptococcal Infection.
What interventions are being tested in trial NCT05175196?
The interventions under investigation include: CandyCollect (DIAGNOSTIC_TEST), Lollipop Swab (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05175196?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05175196 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Group A Streptococcal Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05175196's enrollment target sits among peer trials
210 490th of 2000 higher than 1,505 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI